Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Coal Miner “Black Lung Disease” Workplace Injury Claims Spiked In 2016: CDC December 20, 2016 Russell Maas Add Your Comments Federal safety officials have released a new study that identifies dozens of new black lung disease cases among coal mine workers in the United States, highlighting the need to implement new early detection medical screenings and improved methods to prevent overexposure to coal mine dust, which can develop into a lethal lung disease. The Centers for Disease Control and Prevention (CDC) released a new study last week, warning of a drastic increase in coal worker’s pneumoconiosis this year, commonly referred to as “black lung disease”. The cases were not detected under the Coal Worker’s Health Surveillance Program, which is a national program to detect coal mine dust overexposure. The occupational lung disease known as pneumoconiosis has long been a severe health risk to coal workers, who are overexposed and susceptible to breathing in coal mine dust. The dust inhaled within coal mines commonly leads to inflammation and fibrosis of the lungs, often resulting in a debilitating disease that can result in lung failure or require oxygen treatments, and is frequently lethal. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION During coal mining, the mines are cut, drilled, or ground, releasing a dust in the air that contains crystalline silica particles. The particles released in the air are not visible to the eye and are commonly breathed in by surrounding workers. Coal miners, who are typically exposed to breathing in silica particles in the dust for long periods of time, have been found to be susceptible to silica caused disease such as black lung disease and certain forms of cancer. In 1969 the first federal safety efforts to protect coal workers were established by the passing of the Federal Coal Mine Health and Safety Act, which established dust limits for U.S. coal mines. Shortly after, the National Institute for Occupational Safety and Health (NIOSH) administered a surveillance program known as the Coal Workers’ Health Surveillance Program, to identify, correct and analyze coal mining regions where many reports of coal miner pneumoconiosis cases originated. The goal of the program was to be able to identify ineffective practices and correct dust control methods to mitigate and over time eliminate severe, deadly, progressive forms of lung disease. Despite a decrease in the amount of pneumoconiosis cases reported in the U.S. over several decades, on June 9, 2016, a radiologist from Kentucky reached out to NIOSH representatives to report a recent increase in pneumoconiosis cases within the last two years at local health facilities around the Pike County region surrounding the central Appalachian coalfields. The radiologist submitted a request to NIOSH to assist in conducting an investigation to determine the cause of the increase in pneumoconiosis cases and to help develop an intervention program to reduce the prevalence of cases within the surrounding coalfields. Following a NIOSH investigation, researchers found sixty male patients who were active or former coal miners diagnosed with pneumoconiosis A, B, or C, which are the categories of severity of the disease. Researchers discovered 82%, or 49 patients, were found to have radiographic findings consistent with PMF during the 2016 year alone. Additionally, 31 patients were found to have been diagnosed with category A pneumoconiosis, 23 with category B pneumoconiosis, and six with category C pneumoconiosis readings. A job description analysis of the impacted patients identified that all of the past or present coal mining patients worked directly within the mines operating machinery or as ground crews. As a result of the study and its findings, a new federal rule has been implemented, as part of an increased effort to improve the surveillance program to detect potential black lung disease development. NIOSH has announced it will be expanding their medical surveillance, which will include respiratory symptoms assessments and spirometry testing. The Coal Worker’s Health Surveillance Program has stipulated that active coal miners will now be offered free medical monitoring that will include chest radiographs upon entering the coal mining occupation and follow-up chest radiographs every 5 years. Included in the new federal rules, U.S. coal mines will be mandated to lower the amount of respirable dust in the air through the use of a continuous personal dust monitor. The device will measure in real-time the respirable coal mine dust. The availability of the real-time respirable dust measurements, lower exposure limits, and expanded medical surveillance will be a combination of efforts to prevent future pneumoconiosis cases by detecting early signs or respiratory impairment before the conditions worsen to debilitating degrees. Additional research will be required to determine what has caused the increase in coal mining pneumoconiosis cases. According to the researchers from NIOSH, due to the long time it takes for black-lung disease to manifest, it is difficult to determine whether former, outdated coal mining practices caused the increase in pneumoconiosis cases, or if current mining practices have contributed to the recent influx. Tags: Black Lung Disease, Coal Miner, Lung Cancer, Respiratory, Work Injury More Lawsuit Stories Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit March 25, 2025 Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025 Cases of Persistent Delirium at Nursing Homes Dropped in Recent Years: Study March 25, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025) Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025) Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)
Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)